Child & Family Research Institute

The Child & Family Research Institute conducts discovery, translational and clinical research to benefit the health of children and their families. CFRI is supported by BC Children’s Hospital Foundation and works in close partnership with BC Children’s Hospital, the Provincial Health Services Authority and its agencies, and the University of British Columbia. For more information, visit www.cfri.ca.

CFRI Summer Student Research Program

The Child & Family Research Institute’s Summer Student Research Program fosters research awareness and interest in the undergraduate and medical community. Since 1987, the program has provided more than 800 students an opportunity to participate in research projects related to child and family health under the supervision of researchers from the Child & Family Research Institute, BC Children’s Hospital & BC Women’s Hospital & Health Centre. For more information, visit www.cfri-training.ca/ssrp.

Qu Biologics

Qu Biologics develops Site Specific Immunomodulators (SSI), a novel class of immunotherapies that aim to restore the body’s normal immune response. SSIs are designed to stimulate an innate immune response in targeted organs or tissues to reverse the chronic inflammation underlying many illnesses, including cancer and inflammatory bowel disease.

Since our inception in 2007, we have developed a platform of immunomodulators, demonstrated efficacy in a variety of animal models, conducted a compassionate use program of 272 patients with advanced cancer, inflammatory bowel disease and autoimmune arthritis with promising early results, attracted investment from a strong group of long term committed investors, and initiated three clinical trials in Crohn’s disease, ulcerative colitis and lung cancer. We attribute this success to the character, passion, integrity and collaborative efforts of the talented professionals we continue to attract to our team.

Backed by a prestigious group of scientific advisors and board members, Qu Biologics is led by a management team that includes co-founder and CEO Dr. Hal Gunn, a physician and expert on the body’s immune response to chronic disease, Chief Medical Officer Dr. Simon Sutcliffe, former CEO of the BC Cancer Agency and a distinguished clinician, scientist and leader in cancer control internationally, and Chief Scientific Officer Dr. David Mullins, Assistant Professor of Microbiology and Immunology in the Norris Cotton Cancer Center at the Geisel School of Medicine at Dartmouth, and recognized expert in immune cell trafficking to tumours.  For more information, visit www.qubiologics.com and www.quibd.com.

At iQmetrix, our purpose is to create great retail experiences. Our products bridge the gap between physical and virtual retail channels. XQ Interactive Retail brings elements of online shopping into the physical store to facilitate the purchase process. RQ Retail Management is a modular system for managing all aspects of a store chain operation. Founded in 1999, iQmetrix is a privately-held software as a service (SaaS) company with offices in Canada, the U.S. and Australia.

For more than fifty years, the Department of Biochemistry and Molecular Biology has played an active and important role at UBC and in the greater scientific community.
Home to many internationally recognized researchers, work in the department is focused on subjects of great interest to the general public. Researchers in the Department study many important diseases including cancer, diabetes, blindness, heart disease and inflammation. Together with others in the Departments who focus on drug research, they are working to both understand these issues and develop treatments and cures. Other major aspects of the Department’s research focus on developing new antibiotics: this is an urgent priority since resistance to existing drugs is so prevalent around the world. Several members of the Department are working to understand how the function of genes is controlled. The excellence of our research is amply demonstrated by the fact that several members of the Department have been recognized by major research prizes.

The Department of Microbiology and Immunology at the University of British Columbia provides a stimulating environment in which to pursue a graduate or undergraduate research program. Our faculty is internationally recognized for contributions in microbiology, molecular biology and immunology. Students will have the opportunity to experience the most up to date molecular approaches to the study of problems in microbiology and immunology.
Clif Bar and Company started on a bike ride. Our founder, Gary, took a bite of another energy bar and thought to himself: “I could make a better bar than this.” Today, we still want to make things better. Our food. Our company. Even our planet. We’ll keep working on it.

There’s healthy. There’s tasty. Then there’s healthy and tasty. At KIND®, we believe you deserve both—we call it our brAND philosophy. What began with just 8 bar varieties in 2004 has grown to over 22 bars and 6 Healthy Grains snackable clusters, and a multitude of new recipes being perfected and refined to our standards in the KIND® kitchen.
So whether your snacking style is choosy or adventurous (or a little bit of both), here’s something to celebrate: we’ll always be thinking up new ways to delight your taste buds and keep your body happy.